This drug is indicated in adults with recent respiratory disease with difficulty in expectoration (difficulty in rejecting by spitting bronchial secretions).
< Code>

Oral use.

This specialty is suitable for patients on a hypoglucidic or hypocaloric diet.

1 tablespoon of 15 ml, contains 750 mg of carbocistein.

The usual dosage is 750 mg per dose, taking 3 times a day, ie 1 tablespoon (15 ml) 3 times a day. >
Duration of processing

It must be brief and not exceed 5 days.

Pharmacotherapeutic group: MUCOLYTIC, ATC code: R05CB03.

(R: respiratory system).

Carbocistein is a muco-type muco-modulator. It exerts its action on the gel phase of the mucus, presumably by breaking the bridges, disulfides of the glycoproteins, and thus promotes the expectoration.
Not applicable.

· A history of hypersensitivity to one of the components (including methyl parahydroxybenzoate).

Special warnings

The productive coughs, which represent a fundamental element of broncho-pulmonary defense, must be respected.

The association of mucomodifiers, bronchodilators with antitussives and / or substances, drying (atropinic) secretions is irrational

Special precautions for use

Caution is advised in patients with peptic ulcers.

This medication contains sodium, which contains 99.39 mg of sodium per tablespoon (15 ml) of syrup. To be taken into account in patients on a low-sodium diet, strict.

This drug contains 0.796% ethanol (alcohol), ie up to 285 mg of ethanol per maximum daily dose, which is equivalent to 7.16 ml of beer or 2, 98 ml of wine per day. The use of this medication is dangerous in alcoholics and should be taken into account in pregnant or lactating women, children and high-risk groups such as inadequate, hepatic or epileptic. Br>

Not applicable.

Not applicable.

Not applicable.


Studies in animals have not shown any teratogenic effect. In the absence of available clinical data, precaution should be taken to avoid the administration of this product during pregnancy.

In case of breast-feeding, the use of this product is not recommended.
Possible phenomena of digestive intolerance (gastralgia, nausea, diarrhea). It is then advisable to reduce the dose.

Possibility of allergic skin reactions such as urticaria, angioedema, pruritus, rash, erythematosus. Some cases of erythema, fixed pigmented have been reported.

Due to the presence of methyl parahydroxybenzoate, risk of reactions, allergic eventually delayed.

< Code>